Skip to main content
SpringerLink
Log in

On pharmacogenomics and cost-effectiveness analysis at the individual level

  • Correspondence
  • Published:
PharmacoEconomics Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Bala MV, Zarkin GA. Pharmacogenomics and the evolution of healthcare: is it time for cost-effectiveness analysis at the individual level? Pharmacoeconomics 2004; 22 (8): 495–8

    Article  PubMed  Google Scholar 

  2. La Caze A. Does pharmacogenomics provide an ethical challenge to the utilisation of cost-effectiveness analysis by public health systems?. Pharmacoeconomics 2005; 23 (5): 447–50

    Google Scholar 

  3. Wagstaff A. QALYs and the equity-efficiency tradeoff. In: Cost-benefit analysis. Cambridge: Cambridge University Press, 1994: 428–47

    Chapter  Google Scholar 

  4. Ubel PA, DeKay ML, Baron J, et al. Cost-effectiveness analysis in a setting of budget constraints. N Engl J Med 1996; 334: 1174–7

    Article  PubMed  CAS  Google Scholar 

  5. Johannesson M, Gerdtham U. A note on the estimation of the equity-efficiency trade-off for QALYs. J Health Econ 1996 Jun; 15 (3): 359–68

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgements

No sources of funding were used to assist in the preparation of this editorial. The author has no conflicts of interest that are directly relevant to the content of this editorial.

Author information

Authors and Affiliations

  1. Centocor Inc., Malvern, PA, USA

    Mohan V. Bala

  2. Research Triangle Institute, Research Triangle Park, NC, USA

    Gary A. Zarkin

Authors
  1. Mohan V. Bala
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Gary A. Zarkin
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bala, M.V., Zarkin, G.A. On pharmacogenomics and cost-effectiveness analysis at the individual level. Pharmacoeconomics 23, 527 (2005). https://doi.org/10.2165/00019053-200523050-00011

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00019053-200523050-00011

Keywords

Search

Navigation